Jennifer Lachey - Chief Scientific Officer at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jennifer Lachey since 12 Feb 2025

Holdings reported by Jennifer Lachey for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 95,100 $4,307,079 $45.29 15 Jul 2022 Direct
of Shares Employee Stock Option (right to buy) 76,705 04 Apr 2022 Direct Common Stock
Employee Stock Option (right to buy) 8,755 15 Jul 2022 Direct Common Stock

Transactions reported by Jennifer Lachey for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.